FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146285369> ?p ?o ?g. }

• W2146285369 abstract "Lung cancer is one of the leading causes of cancer-related mortality worldwide. Conventional chemotherapy and radiotherapy are the primary therapeutic methods for lung cancer with the use of combination therapies gaining popularity. The frequency and duration of treatment, as well as, managing lung cancer by targeting multiple aspects of cancer biology is often limited by toxicity to the patient. There are many naturally occurring anticancer agents that have a high degree of efficacy and low toxicity, offering a viable and safe approach for the treatment of lung cancer. The herbs traditionally used in Chinese medicine for anticancer treatment offer great potential to enhance the efficacy of conventional therapy. In this study, we evaluated the synergistic effects of Fei-Liu-Ping (FLP) ointment in treating lung cancer; a known anticancer Chinese herbal based formula. In this study, A549 human lung carcinoma cell line and Lewis lung carcinoma xenograft mouse model were used. In addition, we utilized an in vitro co-culture system to simulate the tumor microenvironment in order to evaluate the molecular mechanisms of FLP treatment. FLP treatment significantly inhibited tumor growth in the Lewis lung xenograft by 40 percent, compared to that of cyclophosphamide (CTX) of 62.02 percent. Moreover, combining FLP and CTX inhibited tumor growth by 83.23 percent. Upon evaluation, we found that FLP treatment reduced the concentration of serum pro-inflammatory cytokines IL-6, TNF-α, and IL-1β. In addition, we also found an improvement in E-cadherin expression and inhibition of N-cadherin and MMP9. We found similar findings in vitro when we co-cultured A549 cells with macrophages. FLP treatment inhibited A549 cell growth, invasion and metastasis, in part, through the regulation of NF-κB and altering the expression of E-cadherin, N-cadherin, MMP2 and MMP9. FLP exerts anti-inflammatory properties in the tumor microenvironment, which may contribute to its anticancer effects. FLP treatment may be a promising therapy for inflammation associated lung cancer treatment alone, or in combination with conventional therapies and may prevent lung cancer metastasis." @default.
• W2146285369 created "2016-06-24" @default.
• W2146285369 creator A5005303316 @default.
• W2146285369 creator A5025687237 @default.
• W2146285369 creator A5032062559 @default.
• W2146285369 creator A5037773587 @default.
• W2146285369 creator A5043300709 @default.
• W2146285369 creator A5081675173 @default.
• W2146285369 creator A5084325188 @default.
• W2146285369 date "2014-05-12" @default.
• W2146285369 modified "2023-09-23" @default.
• W2146285369 title "Fei-Liu-Ping ointment inhibits lung cancer growth and invasion by suppressing tumor inflammatory microenvironment" @default.
• W2146285369 cites W1979521500 @default.
• W2146285369 cites W1987473368 @default.
• W2146285369 cites W1992885568 @default.
• W2146285369 cites W1994621410 @default.
• W2146285369 cites W1995249913 @default.
• W2146285369 cites W2007456673 @default.
• W2146285369 cites W2007470751 @default.
• W2146285369 cites W2010397777 @default.
• W2146285369 cites W2023505415 @default.
• W2146285369 cites W2023898364 @default.
• W2146285369 cites W2035121795 @default.
• W2146285369 cites W2042047630 @default.
• W2146285369 cites W2043892945 @default.
• W2146285369 cites W2053342530 @default.
• W2146285369 cites W2060797461 @default.
• W2146285369 cites W2072076152 @default.
• W2146285369 cites W2083623093 @default.
• W2146285369 cites W20888715 @default.
• W2146285369 cites W2101327682 @default.
• W2146285369 cites W2121296674 @default.
• W2146285369 cites W2123105952 @default.
• W2146285369 cites W2125051557 @default.
• W2146285369 cites W2125570177 @default.
• W2146285369 cites W2128069079 @default.
• W2146285369 cites W2132932211 @default.
• W2146285369 cites W2140551998 @default.
• W2146285369 cites W2145400898 @default.
• W2146285369 cites W2160566324 @default.
• W2146285369 cites W2164823502 @default.
• W2146285369 cites W2335925695 @default.
• W2146285369 cites W2470223656 @default.
• W2146285369 cites W2783677708 @default.
• W2146285369 cites W4362218836 @default.
• W2146285369 doi "https://doi.org/10.1186/1472-6882-14-153" @default.
• W2146285369 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4036108" @default.
• W2146285369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24885825" @default.
• W2146285369 hasPublicationYear "2014" @default.
• W2146285369 type Work @default.
• W2146285369 sameAs 2146285369 @default.
• W2146285369 citedByCount "22" @default.
• W2146285369 countsByYear W21462853692015 @default.
• W2146285369 countsByYear W21462853692016 @default.
• W2146285369 countsByYear W21462853692017 @default.
• W2146285369 countsByYear W21462853692018 @default.
• W2146285369 countsByYear W21462853692019 @default.
• W2146285369 countsByYear W21462853692020 @default.
• W2146285369 countsByYear W21462853692021 @default.
• W2146285369 countsByYear W21462853692022 @default.
• W2146285369 crossrefType "journal-article" @default.
• W2146285369 hasAuthorship W2146285369A5005303316 @default.
• W2146285369 hasAuthorship W2146285369A5025687237 @default.
• W2146285369 hasAuthorship W2146285369A5032062559 @default.
• W2146285369 hasAuthorship W2146285369A5037773587 @default.
• W2146285369 hasAuthorship W2146285369A5043300709 @default.
• W2146285369 hasAuthorship W2146285369A5081675173 @default.
• W2146285369 hasAuthorship W2146285369A5084325188 @default.
• W2146285369 hasBestOaLocation W21462853691 @default.
• W2146285369 hasConcept C121608353 @default.
• W2146285369 hasConcept C126322002 @default.
• W2146285369 hasConcept C143998085 @default.
• W2146285369 hasConcept C2776107976 @default.
• W2146285369 hasConcept C2776256026 @default.
• W2146285369 hasConcept C2776694085 @default.
• W2146285369 hasConcept C2777714996 @default.
• W2146285369 hasConcept C2777847059 @default.
• W2146285369 hasConcept C2778807442 @default.
• W2146285369 hasConcept C2779013556 @default.
• W2146285369 hasConcept C29730261 @default.
• W2146285369 hasConcept C502942594 @default.
• W2146285369 hasConcept C71924100 @default.
• W2146285369 hasConcept C98274493 @default.
• W2146285369 hasConceptScore W2146285369C121608353 @default.
• W2146285369 hasConceptScore W2146285369C126322002 @default.
• W2146285369 hasConceptScore W2146285369C143998085 @default.
• W2146285369 hasConceptScore W2146285369C2776107976 @default.
• W2146285369 hasConceptScore W2146285369C2776256026 @default.
• W2146285369 hasConceptScore W2146285369C2776694085 @default.
• W2146285369 hasConceptScore W2146285369C2777714996 @default.
• W2146285369 hasConceptScore W2146285369C2777847059 @default.
• W2146285369 hasConceptScore W2146285369C2778807442 @default.
• W2146285369 hasConceptScore W2146285369C2779013556 @default.
• W2146285369 hasConceptScore W2146285369C29730261 @default.
• W2146285369 hasConceptScore W2146285369C502942594 @default.
• W2146285369 hasConceptScore W2146285369C71924100 @default.
• W2146285369 hasConceptScore W2146285369C98274493 @default.
• W2146285369 hasIssue "1" @default.
• W2146285369 hasLocation W21462853691 @default.
• W2146285369 hasLocation W21462853692 @default.

• next